Elevate Rehab, Llc - Medicare in Lander, WY

Elevate Rehab, Llc is a medicare enrolled "Clinic/center - Physical Therapy" provider in Lander, Wyoming. Their current practice location is 535 E Main St Ste D, Lander, Wyoming. You can reach out to their office (for appointments etc.) via phone at (307) 335-3471.

Elevate Rehab, Llc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Elevate Rehab, Llc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1003257601.

Contact Information

Elevate Rehab, Llc
535 E Main St Ste D,
Lander, WY 82520-3424
(307) 335-3471
(307) 332-5388



Healthcare Provider's Profile

Full NameElevate Rehab, Llc
TypeFacility
SpecialityClinic/center - Physical Therapy
Location535 E Main St Ste D, Lander, Wyoming
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1003257601
  • Provider Enumeration Date: 07/11/2013
  • Last Update Date: 12/09/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 4981838687
  • Enrollment ID: O20131014000145

Medical Identifiers

Medical identifiers for Elevate Rehab, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003257601NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2251X0800XPhysical Therapist - Orthopedic (* (Not Available))Secondary
225X00000XOccupational Therapist OTR-814 (Wyoming)Secondary
225XE1200XOccupational Therapist - Ergonomics OTR-814 (Wyoming)Secondary
225XH1200XOccupational Therapist - Hand OTR-814 (Wyoming)Secondary
225XN1300XOccupational Therapist - Neurorehabilitation OTR-814 (Wyoming)Secondary
225XP0019XOccupational Therapist - Physical Rehabilitation OTR-814 (Wyoming)Secondary
225XP0200XOccupational Therapist - Pediatrics OTR-814 (Wyoming)Secondary
261QP2000XClinic/center - Physical Therapy (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Elevate Rehab, Llc acts as a billing entity for following providers:
Provider NameCourtney L Hansen
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1003838640
PECOS PAC ID: 2668408162
Enrollment ID: I20050715000759

News Archive

Integra makes multichannel pipetting quicker and easier than ever before

INTEGRA is making multichannel pipetting quicker and easier than ever before. The company's extensive range of manual and electronic handheld pipettes – combined with the revolutionary GripTips system – is helping take the ‘pain' out of multichannel pipetting, boosting productivity and ensuring happy, healthy staff.

Researchers link organ transplant drug to rise in rare lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.

'Mystery patients' study says doctors can miss health's social determinants

Chicago Tribune: So-called "mystery patients" are showing that doctors often ignore or fail to ask about social determinants when it comes to health outcomes, a recent study suggests, for exampel, testing an emaciated patient for cancer before asking if he got enough to eat (he didn't).

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

Read more Medical News

› Verified 7 days ago

Provider NameMichelle L Mazur
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1114061611
PECOS PAC ID: 7315976081
Enrollment ID: I20090904000168

News Archive

Integra makes multichannel pipetting quicker and easier than ever before

INTEGRA is making multichannel pipetting quicker and easier than ever before. The company's extensive range of manual and electronic handheld pipettes – combined with the revolutionary GripTips system – is helping take the ‘pain' out of multichannel pipetting, boosting productivity and ensuring happy, healthy staff.

Researchers link organ transplant drug to rise in rare lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.

'Mystery patients' study says doctors can miss health's social determinants

Chicago Tribune: So-called "mystery patients" are showing that doctors often ignore or fail to ask about social determinants when it comes to health outcomes, a recent study suggests, for exampel, testing an emaciated patient for cancer before asking if he got enough to eat (he didn't).

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

Read more Medical News

› Verified 7 days ago

Provider NameRyan M Flatt
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1689015448
PECOS PAC ID: 7214171602
Enrollment ID: I20130925000662

News Archive

Integra makes multichannel pipetting quicker and easier than ever before

INTEGRA is making multichannel pipetting quicker and easier than ever before. The company's extensive range of manual and electronic handheld pipettes – combined with the revolutionary GripTips system – is helping take the ‘pain' out of multichannel pipetting, boosting productivity and ensuring happy, healthy staff.

Researchers link organ transplant drug to rise in rare lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.

'Mystery patients' study says doctors can miss health's social determinants

Chicago Tribune: So-called "mystery patients" are showing that doctors often ignore or fail to ask about social determinants when it comes to health outcomes, a recent study suggests, for exampel, testing an emaciated patient for cancer before asking if he got enough to eat (he didn't).

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

Read more Medical News

› Verified 7 days ago

Provider NameKatelin R Tucker
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1568726081
PECOS PAC ID: 7315197746
Enrollment ID: I20171030003340

News Archive

Integra makes multichannel pipetting quicker and easier than ever before

INTEGRA is making multichannel pipetting quicker and easier than ever before. The company's extensive range of manual and electronic handheld pipettes – combined with the revolutionary GripTips system – is helping take the ‘pain' out of multichannel pipetting, boosting productivity and ensuring happy, healthy staff.

Researchers link organ transplant drug to rise in rare lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.

'Mystery patients' study says doctors can miss health's social determinants

Chicago Tribune: So-called "mystery patients" are showing that doctors often ignore or fail to ask about social determinants when it comes to health outcomes, a recent study suggests, for exampel, testing an emaciated patient for cancer before asking if he got enough to eat (he didn't).

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

Read more Medical News

› Verified 7 days ago

Provider NameStephen Elmer
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1588226518
PECOS PAC ID: 9234469214
Enrollment ID: I20190918002462

News Archive

Integra makes multichannel pipetting quicker and easier than ever before

INTEGRA is making multichannel pipetting quicker and easier than ever before. The company's extensive range of manual and electronic handheld pipettes – combined with the revolutionary GripTips system – is helping take the ‘pain' out of multichannel pipetting, boosting productivity and ensuring happy, healthy staff.

Researchers link organ transplant drug to rise in rare lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.

'Mystery patients' study says doctors can miss health's social determinants

Chicago Tribune: So-called "mystery patients" are showing that doctors often ignore or fail to ask about social determinants when it comes to health outcomes, a recent study suggests, for exampel, testing an emaciated patient for cancer before asking if he got enough to eat (he didn't).

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

Read more Medical News

› Verified 7 days ago

Provider NameErin L Smiley
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1538485008
PECOS PAC ID: 7719148139
Enrollment ID: I20210812002561

News Archive

Integra makes multichannel pipetting quicker and easier than ever before

INTEGRA is making multichannel pipetting quicker and easier than ever before. The company's extensive range of manual and electronic handheld pipettes – combined with the revolutionary GripTips system – is helping take the ‘pain' out of multichannel pipetting, boosting productivity and ensuring happy, healthy staff.

Researchers link organ transplant drug to rise in rare lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.

'Mystery patients' study says doctors can miss health's social determinants

Chicago Tribune: So-called "mystery patients" are showing that doctors often ignore or fail to ask about social determinants when it comes to health outcomes, a recent study suggests, for exampel, testing an emaciated patient for cancer before asking if he got enough to eat (he didn't).

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

Read more Medical News

› Verified 7 days ago

Provider NameMartha M Watt
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1346600509
PECOS PAC ID: 5395035844
Enrollment ID: I20211230001158

News Archive

Integra makes multichannel pipetting quicker and easier than ever before

INTEGRA is making multichannel pipetting quicker and easier than ever before. The company's extensive range of manual and electronic handheld pipettes – combined with the revolutionary GripTips system – is helping take the ‘pain' out of multichannel pipetting, boosting productivity and ensuring happy, healthy staff.

Researchers link organ transplant drug to rise in rare lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.

'Mystery patients' study says doctors can miss health's social determinants

Chicago Tribune: So-called "mystery patients" are showing that doctors often ignore or fail to ask about social determinants when it comes to health outcomes, a recent study suggests, for exampel, testing an emaciated patient for cancer before asking if he got enough to eat (he didn't).

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Elevate Rehab, Llc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Elevate Rehab, Llc
535 E Main St Ste D,
Lander, WY 82520-3424

Ph: (307) 335-3471
Elevate Rehab, Llc
535 E Main St Ste D,
Lander, WY 82520-3424

Ph: (307) 335-3471

News Archive

Integra makes multichannel pipetting quicker and easier than ever before

INTEGRA is making multichannel pipetting quicker and easier than ever before. The company's extensive range of manual and electronic handheld pipettes – combined with the revolutionary GripTips system – is helping take the ‘pain' out of multichannel pipetting, boosting productivity and ensuring happy, healthy staff.

Researchers link organ transplant drug to rise in rare lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.

'Mystery patients' study says doctors can miss health's social determinants

Chicago Tribune: So-called "mystery patients" are showing that doctors often ignore or fail to ask about social determinants when it comes to health outcomes, a recent study suggests, for exampel, testing an emaciated patient for cancer before asking if he got enough to eat (he didn't).

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

Read more News

› Verified 7 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.